NCT01373502

International Randomized Comparison Between DES Limus Carbostent and Taxus DES in the Treatment of De-novo Coronary Lesions

International Randomized Comparison Between DES Limus Carbostent and Taxus Drug Eluting Stents in the Treatment of De-novo Coronary Lesions. The NEXT Study.

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 323 (actual)
• Sponsor: CID - Carbostent & Implantable Devices · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to demonstrate non-inferiority in terms of safety and efficacy of DES Limus Carbostent compared to the Taxus Liberté in treating de-novo atherosclerotic lesions in native coronary arteries.

Conditions

• Stable Angina
• Unstable Angina
• Documented Silent Ischemia

Interventions

Type	Name	Description
DEVICE	DES Limus Carbostent	DES Limus Carbostent Carbofilm Coated Coronary Stent
DEVICE	Taxus Liberté Stent	Taxus Liberté Coronary Stent

Timeline

• Start date: 2009-10-01
• Primary completion: 2011-04-01
• Completion: 2015-10-01
• First posted: 2011-06-15
• Last updated: 2018-04-30

Locations

11 sites across 4 countries: Belgium, France, Germany, Italy